Trial: 202009027

A Phase 1 Study of ION251 Administered by Intravenous Infusion to Patients with Relapsed/Refractory Multiple Myeloma

Phase

I

Principal Investigator

Stockerl-Goldstein, Keith

Disease Site

Multiple Myeloma

Learn more about this study at: clinicaltrials.gov